“A really great program that has enabled several important contacts for our company and helped to grow as a entrepreneur.” Harri, Sartar Therapeutics
“Surgify received highly important expert advice and international networks from the SPARK Finland -program. This is the place-to-be for a starting medtech entrepreneur!”


SPARKees – our teams

See alumni teams
Batch: Spring 2024
NeuroEye Insight

Batch: Spring 2024

Opportunistic Screening of Alzheimer's Disease Using Retinal Imaging

Contact person: Sebastian Högnabba


    Batch: Spring 2024

    Developing MYC-dependency targeting drugs to treat cancer

    Contact person: Juha Klefström


    Batch: Spring 2024

    Development of powerful protein-based vaccine technologies

    Contact person: Minna Hankaniemi


    Batch: Spring 2024

    Validation of biomarkers for the detection of stroke type and onset.

    Contact person: Helike Lõhelaid


    Batch: Spring 2024

    Development of novel cellular stress regulators for the treatment of neurological and metabolic diseases

    Contact person: Vera Kovaleva


      Batch: Spring 2024

      Pocket sized microscope that solves the challenges faced by research and diagnostic labs.

      Contact person: Igor Shevkunov

      Batch: Fall 2023
      KAJO Neurotechnologies

      Batch: Fall 2023

      Developing pathophysiologically relevant in vitro models for human neurodegenerative disorders for drug discovery

      Contact person: Joel Noutere


      Batch: Fall 2023

      A novel, non-invasive approach for cancer screening and diagnosis

      Contact person: Andrew Erickson

        MIND’S EYE

        Batch: Fall 2023

        Timely diagnostics of developmental conditions with eye tracking

        Contact person: Anna Ptukha


          Batch: Fall 2023

          Developing and new tumour-specific agent designed to diagnose and treat metastatic brain tumours.

          Contact person: Pirjo Laakkonen


          Batch: Fall 2023

          Accelerating preclinical epilepsy drug development with brain-on-chip

          Contact person: Susanna Narkilahti


          Batch: Fall 2023

          Cancer immunotherapy testing on a chip

          Contact person: Heidi Haikala

          Batch: Spring 2023
          MIOR Immunotherapy

          Batch: Spring 2023

          Developing new immunotherapies for cancer

          Contact person: Carlos Rogerio Figueiredo


          Batch: Spring 2023

          Immunoliposomes to detect rupture prone intracranial aneurysms

          Contact person: Behnam Rezai Jahromi


          Batch: Spring 2023

          Non-invasive method to diagnose intestinal diseases

          Contact person: Lauri Polari

          Avec D

          Batch: Spring 2023

          Intra-articular calcipotriol for treatment of (osteo)arthritis

          Contact person: Johanna Huhtakangas

          Natal Mind

          Batch: Spring 2023

          Digital therapeutics treatment for fear of childbirth

          Contact person: Annika Järvelin


          Batch: Spring 2023

          DNA Nanoswitches-enabled Visual Colorimetric Diagnostics

          Contact person: Jacky Loo


            Batch: Spring 2023

            Next-generation bioinks for 3D bioprinting living tissues and organs

            Contact person: Anni Mörö


            Batch: Spring 2023

            Improved early-stage cancer detection and sensitive disease monitoring

            Contact person: Pyry Helkkula


            Batch: Spring 2023

            Early intervention for hearing health

            Contact person: Tanja Tervonen


            Batch: Spring 2023

            Novel method for optimized and personalized labor induction care

            Contact person: Hanna Castrén-Niemi

            Batch: Fall 2022

            Batch: Fall 2022

            A smart optical sensor for arthroscopic surgery

            Contact person: Isaac Afara


            Batch: Fall 2022

            Graphene based dry electrodes for biometric measurements

            Contact person: Teemu Ruotsalainen


            Batch: Fall 2022

            Protein production optimization

            Contact person: Rashad Ismayilzada


            Batch: Fall 2022

            (Former ER4Surgery) Image-guided surgery without Instruments.

            Contact person: Paavo Vartiainen

            3D CelluGel

            Batch: Fall 2022

            A Novel Cell Growth Matrix by 3D Printing of Biopolymers

            Contact person: Chunlin Xu

            Batch: Spring 2022

            Batch: Spring 2022

            Digital hearing diagnostics

            Contact person: Aarno Dietz


              Batch: Spring 2022

              Light- reconfigurable substrate for cell cultures

              Contact person: Arri Priimägi


              Batch: Spring 2022

              Delivery of encapsulated mitochondria as novel pharmaceutical solution

              Contact person: Hongbo Zhang

              Multivision Diagnostics

              Batch: Spring 2022

              Automated and scalable tool for precision diagnosis and personalized treatment

              Contact person: Karolina Punovuori

              Batch: Fall 2021

              Batch: Fall 2021

              AI for the detection of heart transplant rejection

              Contact person: Juha Peltonen


              Batch: Fall 2021

              Novel method for diagnosing respiratory suppression

              Contact person: Antti Vehkaoja


              Batch: Fall 2021

              Non-invasive solution to support rehabilitation from AUD.

              Got into SmiLe Incubator (Lund, SWE).

              Contact person: Jukka Planman


              Batch: Fall 2021

              Diaper embedded biosensor platform, that screens abnormal clinical conditions

              Contact person: Oguz Tanzer


              Batch: Fall 2021

              Viability analysis of organ transplants, and neuronal and cardiac implants

              Contact person: Jarno Tanskanen


              Batch: Fall 2021

              MechScopy provides mechanical microscopy with the goal of making cancer 3D cell cultures reproducible and physiological.

              Contact person: Juho Pokki

              Batch: Spring 2021

              Batch: Spring 2021

              Rapid diagnostics of human picornaviruses based on viral proteases

              Contact person: Petri Susi


              Batch: Spring 2021

              Novel method for histology

              Contact person: Ilkka Paatero


              Batch: Spring 2021

              mTMS – multilocus transcranial magnetic stimulation

              Contact person: Kicic Dubravko


              Batch: Spring 2021

              Poly(jasmine lactone): A Versatile Platform for Drug Delivery

              Contact person: Kuldeep Bansal

              Batch: 2020

              Batch: 2020

              Method for objective assessment of infant motor development.

              Contact person: Sampsa Vanhatalo


              Batch: 2020

              Tissue specific therapy for skin diseases

              Contact person: Tero Järvinen


              Batch: 2020

              Functional brain imaging reshaped

              Contact person: Marko Havu


              Alumni: 2018
              Team Scheperjans

              Batch: Spring 2018

              Microbiome therapy for Parkinson’s disease.
              IP turned into NeuroBiome Oy that has contract with a large company

              Contact person: Filip Scheperjans


              Batch: Fall 2017

              Tissue analysis for breast cancer surgery.
              Spin-out to Olfactomics Oy

              Contact person: Antti Roine


              Batch: Pilot 2016 / Spring 2017

              Nano structure for bioimaging.
              Spin-out to XFold Imaging Oy

              Contact person: Timo Jäntti


              Batch: Pilot 2016 / Spring 2017

              Caries and infection prevention and treatment.

              Spin-out to Koite Health Oy

              Contact person: Tommi Pätilä


              Batch: Pilot 2016 / Spring 2017

              Safety mechanism for surgical drills.

              Spin-out to Surgify Medical Oy

              Contact person: Visa Sippola

              Alumni: 2019
              Liquid Biopsy Solutions

              Batch: Fall 2018

              Laboratory and computational method for liquid biopsies.
              Spin-out to Genomill Health Oy

              Contact person: Manu Tamminen

              PPI Modulators

              Batch: Fall 2018

              Rational discovery of protein-protein interaction modulators.

              Spin-out to Aurlide Oy

              Contact person: Olli Pentikäinen


              Batch: Spring 2018

              Light controlled protein production.
              An alumni due Project Manager got recruited to Bayer.

              Contact person: Jari Rossi


              Batch: Spring 2018

              Extra cellular vesicle solution for bleeding disorders.
              An alumni due Project Manager got recruited to Mayo Clinic (USA).

              Contact person: Mayank Saraswat


              Batch: Spring 2018

              Novel single cell omics methods.
              Spin-out to Scellex Oy

              Contact person: Päivi Saavalainen


              Batch: Fall 2017

              Laser solution for eye treatment.

              Became a development case for industry.

              Contact person: Jukka Viheriälä

              SMART PD

              Batch: Spring 2017

              Peritoneal diagnostics for dialysis patients.
              Spin-out to Smart PD Solutions Oy

              Contact person: Pirgit Silvast-Äikäs


              Batch: Pilot 2016 / Spring 2017

              Cancer drug for GIST.
              Spin out to Sartar Therapeutics Oy

              Contact person: Harri Sihto

              Alumni: 2020

              Batch: 2019

              Vertigo diagnostics for primary care.

              Got remarkable funding for another project.

              Contact person: Tuomas Hyytiä


              Batch: Spring 2018

              Method for extra-cellular vesicle isolation.
              Spin-out under establishment

              Contact person: Maija Puhka


              Batch: Spring 2018

              Method to monitor the oxygenation of myocardial tissue.
              Spin-out to SpectroCor Oy

              Contact person: Kalle Kotilahti


              Batch: Spring 2018

              Novel heat treatment for age related macular degeneration.
              Spin-out to Maculaser Oy

              Contact person: Jani Tirronen

              TB Biofilm

              Batch: Spring 2018

              Mycobacterial biofilms as anti-tuberculosis drug targets.
              Became a cornerstone of an extensive multinational research program.

              Contact person: Mataleena Parikka


              Batch: Spring 2018

              Light-activated antimicrobial surfaces and materials.
              IP acquired by Plasmonics Oy

              Contact person: Alexandre Efimov


              Batch: Fall 2017

              Toxicity test for heart cells.

              Solution in use at FHAIVE, a reference toxicity laboratory for EURL ECVAM.

              Contact person: Tuula Heinonen

              Ocular Surface Precision Panel

              Batch: Spring 2017

              Ocular biomarker panel and analysis.
              Project manager got recruited to another project.

              Contact person: Ulla Aapola

              GreenSeq/ Seqnom

              Batch: Spring 2017

              Microbiological Analyses on (Blue) Bio- and Circular Economies.
              Spin-out to GreenSeq Oy

              Contact person: Kirsi-Maarit Lehto

              Alumni: 2021

              Batch: 2020

              Cardiac Micrograft Therapy™ for treating Ischhemic Scars and Heart Failure.

              Spin-out to EpiHeart Oy.

              Contact person: Kai Kronström


              Batch: 2020

              Long-term oral drug delivery.

              Alumni due Prof. Helder Santos got recruited as Head of Biomedical Engineering at UMCG (Groningen, NED).

              Contact person:


              Batch: 2020

              Natural medication for human papillomavirus (HPV)-associated warts.

              Spin-out to Anison Therapeutics Oy

              Contact person: Preethy Paul

              Algoa Progress

              Batch: 2020

              Personalized treatment planning of osteoarthritis.

              Spin-out to MSK Technologies Oy.

              Contact person: Joona Kemppainen


              Batch: 2019

              Novel treatment for limbal epithelial stem cell deficiency.

              Spin-out to StemSight Oy

              Contact person: Laura Koivusalo


              Batch: 2019

              Topographically tuned and sustainable surfaces for biological applications.

              Potential licensing case. Project manager got recruited as Innovation Manager at UTU.

              Contact person: Erik Niemelä

              Team Scheperjans

              Batch: Spring 2018

              Microbiome diagnostics for Parkinson’s disease.
              IP turned to NeuroBiome Oy that has joint development and licensing agreement.

              Contact person: Filip Scheperjans


              Batch: Fall 2017

              AI solution for toxicity testing.

              Solution in use at FHAIVE, a reference toxicity laboratory for EURL ECVAM.

              Contact person: Dario Greco

              Alumni: 2022

              Batch: 2020

              Smart heart monitoring.

              Spin-out to Sonai Health Oy.

              Contact person: Arto Kotimaa

              Solving the Mesh

              Batch: 2020

              Implantable support to treat pelvic organ prolapse.
              Spin-out to Lignum Medical Oy

              Contact person: Eija Raussi-Lehto


              Batch: 2020

              Indoor air diagnostics with fluorescent C. elegans nematodes.

              Lead to a co-research project.

              Contact person: Päivi Koskinen


              Batch: 2019

              Therapeutics for antimicrobial resistant bacteria.

              Spin-out to Arivin Therapeutics Oy, was accepted to INCATE Incubator.

              Contact person: Christopher Jonkergouw


              Batch: 2019

              Distal radius fractures artificial intelligence diagnostic tool.
              Preparations for a startup in progress.

              Contact person: Jorma Ryhänen


              Batch: 2019

              Ultrasound solution for cancer biopsies
              Spin-out/licensing under development.

              Contact person: Jouni Rantanen


              Batch: 2019

              Simple droplet devices for biomedicine, diagnostics and pharma.
              Got continuing development funding.

              Contact person: Päivi Saavalainen


              Batch: 2019

              Diagnostic test for vitamin B3 metabolism deficiency.

              Spin-out to NADMED Oy

              Contact person: Liliya Euro

              PARKS – Parkinson’s Biomarker Test

              Batch: Fall 2018

              Parkinson’s signature biomarker assay.
              Ongoing large validation study with Michael J Fox Foundation funding.

              Contact person: Eleanor Coffey

              Alumni: 2023

              Batch: Spring 2022

              Mental health platform and services

              Spin-out to Brightlife Oy

              Contact person: Eero Haikonen

              Integrated Secretion Solutions

              Batch: 2020

              Platform for optimized production of biotechnological proteins

              Spin-out to Avenue Biosciences Oy and a startup in the U.S.

              Contact person: Ville Paavilainen

              Alumni: 2024

              Batch: Fall 2021

              Prevention of pressure ulcers
              Manager was recruited as Team Leader to Attendo.

              Contact person: Nuno Nobre


              Batch: Fall 2021

              How to make vaccines thermostable
              Preparing to spin-out a startup.

              Contact person: Manlio Fusciello


              Batch: Spring 2021

              Personalized prediction of the risk for aortic dilatation and rupture.
              Preparing to spin-out a startup.

              Contact person: Marja Hedman


              Batch: 2020

              Accurate correction for QT interval ‒ the most important cardiac risk measure.
              Spin-out to Monicardi Oy

              Contact person: Esa Räsänen


              Batch: 2020

              Functional insight into hypercholesterolemia patients.
              Spin-out to Moncyte Oy

              Contact person: Simon Pfisterer